Abstract
Tea is the second most commonly consumed beverage worldwide. Along with its aromatic and delicate flavors that make it an enjoyable beverage, studies report numerous health advantages in tea consumption, including applications in antimicrobial therapy. The antimicrobial properties of tea are related to catechin and its derivatives, which are natural flavonoids that are abundant in tea. Increasing evidence from in vitro studies demonstrated antimicrobial effects of catechins on both gram-positive and gram-negative bacteria, and proposed direct and indirect therapeutic mechanisms. Additionally, catechins were reported to be effective anti-virulence agents. Furthermore, a number of studies presented evidence that catechins display synergistic effects with certain antibiotics, thus potentiating the activity of antibiotics in resistant bacteria. Despite their numerous beneficial properties, catechins face many challenges in their development as therapeutic agents, including poor absorption, low bioavailability, and rapid degradation. The introduction of nanobiotechnology provides target-based and stable delivery, which enhances catechin bioavailability and optimizes drug efficacy. As further research continues to focus on overcoming the unresolved challenges, catechins are likely to see additional promising applications in our continual fight against bacterial infections.
Highlights
Antibiotic-resistant bacterial infections are one of the most significant global threats to public health
The authors suggested that the low permeability of catechins in negatively charged membranes might explain the relative resistance of gram-negative bacteria to the effects of catechins [14,15]
We studied the mechanism of this activity and found that galloylated catechins significantly change the toxin’s secondary structure
Summary
Antibiotic-resistant bacterial infections are one of the most significant global threats to public health. Catechins are demonstrated to possess a number of promising bactericidal effects on both gram-positive and gram-negative bacteria, including multidrug-resistant strains. These molecules are shown to inhibit virulence factor activity, toxins, reducing the pathogenicity of certain bacteria. The use of novel nanocarriers has helped to overcome these limitations, providing renewed promise of the therapeutic potential of catechins in the fight against antibiotic-resistant bacterial infections. We highlight the many reported uses of catechins to treat bacterial infections and describe biotechnological approaches to overcome the limitations of the molecules.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.